Form D · Other Technology
Insightin Health Inc
Baltimore, MD · CIK 0001845376
Offering snapshot reported Feb 10, 2021 · SEC filing
- Reported sold
- $12.4M Offering amount: $12.4M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 10, 2021 | Initial | $12,370,221 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-389068
This filing covers the sale and issuance of Series A Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Source: Form D, filed Feb 10, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Binoy Bhansali | Director |
| Zachary Giegel | Director |
| Marcia Kepler Noor | Executive |
| Steve Lefar | Director |
| Enam Noor | Director, Executive |
| Scott Sanner | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
333 W. Ostend Street Suite 110
Baltimore, MD, 21230
Baltimore, MD, 21230